IPL + RF for Dry Eye Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment for people with dry eye disease caused by Meibomian gland dysfunction (MGD). The treatment, IPL_RF_MGX, combines intense pulsed light (IPL) and radiofrequency (RF) to evaluate its safety and effectiveness. Participants will receive four treatments over two months, focusing on the area around the eyes. This trial may suit those who regularly experience moderate to severe dry eyes and have been diagnosed with MGD. As an unphased trial, it offers an opportunity to explore innovative treatment options for dry eye disease.
Will I have to stop taking my current medications?
The trial requires a 4-week period without using any prescription eye drops, except for artificial lubricants. Non-prescription products for dry eye should not be used within 1 month of the study, except for artificial lubricants.
What prior data suggests that this combination therapy is safe for treating Dry Eye Disease?
Research has shown that using intense pulsed light (IPL) with radiofrequency (RF) is generally safe for treating dry eye disease caused by meibomian gland dysfunction. One study found that this combination improves symptoms more effectively than using either treatment alone. Although specific safety details aren't mentioned, both IPL and RF are used in other treatments and are generally considered safe. These treatments might cause mild side effects, such as temporary redness or warmth in the treated area. Always consult your doctor to determine if this treatment is suitable for you.12345
Why are researchers excited about this trial?
Researchers are excited about the IPL_RF_MGX treatment for dry eye disease due to meibomian gland dysfunction because it combines three innovative therapies into one regimen. Unlike standard treatments like artificial tears, warm compresses, or eyelid scrubs, this approach uses intense pulsed light (IPL) on the malar region and radiofrequency (RF) around the eyes, which may improve the function of the meibomian glands more effectively. The addition of meibomian gland expression (MGX) further enhances gland clearance. This combination targets the underlying causes of meibomian gland dysfunction, offering a potentially more comprehensive and longer-lasting solution compared to conventional methods.
What evidence suggests that this combination therapy might be an effective treatment for Dry eye disease?
Research has shown that combining intense pulsed light (IPL), radiofrequency (RF), and meibomian gland expression (MGX) can improve dry eye symptoms caused by meibomian gland issues. In this trial, participants will receive this combination treatment, which has provided greater symptom relief compared to past data. A review of past cases revealed that 89% of patients experienced significant relief from dry eye symptoms after receiving IPL and MGX. Studies have also found that IPL-MGX is more effective than MGX alone. Additionally, RF has proven to safely and effectively ease dry eye symptoms. Overall, these treatments together have shown promise in improving the condition.13678
Who Is on the Research Team?
James Chelnis, MD
Principal Investigator
Manhattan Face and Eye
Chantel Garcia, OD
Principal Investigator
Carolina Eye Doctors
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 4 treatments at 2-week intervals, consisting of IPL, RF, and MGX
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- IPL_RF_MGX
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lumenis Ltd.
Lead Sponsor
Lumenis Be Ltd.
Lead Sponsor